Evidence map›Paper›PMID 30962347›Full record

ArticleAntimicrobial agents and chemotherapy2019

Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis

Razieh Kebriaei, Seth A Rice, Kyle C Stamper, Ravin Seepersaud, Cristina Garcia-de-la-Maria, Nagendra N Mishra, Jose M Miro, Cesar A Arias, Truc T Tran, Paul M Sullam and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Membrane Phenotypic, Metabolic and Genotypic Adaptations ofAntibiotics (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Strain-Specific Adaptations ofAntibiotics (Basel, Switzerland) · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Razieh KebriaeiAnti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan, USA.
Seth A RiceAnti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan, USA.
Kyle C StamperAnti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan, USA.
Ravin SeepersaudUniversity of California, San Francisco, San Francisco, California, USA.
Cristina Garcia-de-la-MariaInfectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Nagendra N MishraLA Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California, USA.
Jose M MiroInfectious Diseases Service, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Cesar A AriasCenter for Antimicrobial Resistance and Microbial Genomic, Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, Texas, USA.
Truc T TranCenter for Antimicrobial Resistance and Microbial Genomic, Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, Texas, USA.
Paul M SullamUniversity of California, San Francisco, San Francisco, California, USA.
Arnold S BayerLA Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California, USA.
Michael J RybakAnti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan, USA m.rybak@wayne.edu.
Eugene Applebaum College of Pharmacy and Health Sciences · USUniversitat de Barcelona · ESHarbor–UCLA Medical Center · USSan Francisco VA Medical Center · USThe University of Texas Health Science Center at Houston · USUCLA Medical Center · USUniversidad El Bosque · COUniversity of California, San Francisco · US

Funding

The LiaFSR system and antimicrobial peptide resistance in enterococciR01AI134637 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Cesar Augusto Arias · 2018 to 2026
$3.7M
Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitisR01AI130056 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 2018 to 2022
$2.4M
A Pharmacologic Approach to Prevent Daptomycin Resistance in VRER01AI121400 · NIAID · WAYNE STATE UNIVERSITY · PI RYBAK, MICHAEL JOSEPH · 2016 to 2020
$1.9M
Daptomycin Resistance in Enterococcus faeciumK08AI113317 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TRAN, TRUC THANH · 2014 to 2018
$792k
Molecular basis of the cefazolin inoculum effectR21AI143229 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2019 to 2020
$442k
NIAID NIH HHS K08 AI113317NIAID NIH HHS R01 AI121400NIAID NIH HHS R01 AI130056NIAID NIH HHS R01 AI134637NIAID NIH HHS R21 AI143229
6 · The paper itself

Abstract

The viridans group streptococci (VGS) are a heterogeneous group of organisms which are important components of the normal human oral flora. Among the VGS, the

Indexed as

Anti-Bacterial Agentsbeta-LactamsCeftriaxoneDaptomycinDrug Resistance, BacterialDrug Therapy, CombinationEndocarditisEndocarditis, BacterialHumansMicrobial Sensitivity TestsStreptococcus mitisStreptococcus oralisVancomycinAnti-Bacterial Agentsbeta-LactamsCeftriaxoneDaptomycinVancomycinceftriaxonedaptomycinSEVs

Identifiers

PMID30962347
PMCPMC6535512
OpenAlexW2936094098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.